These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 30183989)
1. Downstream Change of the Primary Endpoint in the ISCHEMIA Trial: the Elephant in the Room. Correia LCL; Rassi Junior A Arq Bras Cardiol; 2018 Aug; 111(2):213-214. PubMed ID: 30183989 [No Abstract] [Full Text] [Related]
7. Results of the Multiple Risk Factor Intervention Trial (MRFIT). Russell RP; Lewis C Md State Med J; 1984 Jan; 33(1):13-4. PubMed ID: 6700270 [No Abstract] [Full Text] [Related]
8. What have we learned from the recent large trials in acute coronary syndromes without ST-segment elevation? Harrington RA; Simoons ML Eur Heart J; 2000 May; 21(9):702-4. PubMed ID: 10739722 [No Abstract] [Full Text] [Related]
9. [The choice between primary angioplasty and thrombolysis: is there any change after GUSTO-IIb?]. Fazzini PF G Ital Cardiol; 1997 Jan; 27(1):79-84. PubMed ID: 9244715 [No Abstract] [Full Text] [Related]
10. [From the results of large trials to the optimal management of a patient]. Onnis E; Iliceto S Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):401-4. PubMed ID: 12497943 [No Abstract] [Full Text] [Related]
11. Percutaneous transluminal coronary angioplasty versus coronary artery bypass. Isn't it time for a randomized trial? Mock MB; Reeder GS; Schaff HV; Holmes DR; Vlietstra RE; Smith HC; Gersh BJ N Engl J Med; 1985 Apr; 312(14):916-9. PubMed ID: 3156275 [No Abstract] [Full Text] [Related]
12. Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: acute coronary syndromes and elective stenting. Granada JF; Kleiman NS Am J Cardiovasc Drugs; 2004; 4(1):31-41. PubMed ID: 14967064 [TBL] [Abstract][Full Text] [Related]
13. Strength of conclusion attained from a clinical trial of thrombolysis will depend considerably on interpretation of changes in end-points other than mortality. Spodick DH Am J Med; 1983 Jan; 74(1):159-60. PubMed ID: 6849325 [No Abstract] [Full Text] [Related]
14. The BARI trial: baseline observations. The BARI Investigators. Frye RL; Sopko G; Detre KM Trans Am Clin Climatol Assoc; 1993; 104():26-30. PubMed ID: 1343445 [No Abstract] [Full Text] [Related]
15. Revascularization procedures in the treatment of single-vessel coronary disease. Parisi AF; Burtt DM Coron Artery Dis; 1993 Dec; 4(12):1053-60. PubMed ID: 7909263 [No Abstract] [Full Text] [Related]
16. Results of recent trials on the progression of coronary artery disease and recurrent ischemic events: implications for interventional cardiology. Pitt B J Interv Cardiol; 1994 Dec; 7(6):515-8. PubMed ID: 10155198 [No Abstract] [Full Text] [Related]
17. Percutaneous coronary intervention in China: registries and trials. Gao R Indian Heart J; 2007; 59(2 Suppl B):B16-9. PubMed ID: 19153430 [No Abstract] [Full Text] [Related]
18. Angiogenesis and the heart: therapeutic implications. Hariawala MD; Sellke FW J R Soc Med; 1997 Jun; 90(6):307-11. PubMed ID: 9227376 [No Abstract] [Full Text] [Related]